Role  ||| S:0 E:5 ||| NN
of  ||| S:5 E:8 ||| IN
low-level  ||| S:8 E:18 ||| JJ
laser  ||| S:18 E:24 ||| NN
therapy  ||| S:24 E:32 ||| NN
in  ||| S:32 E:35 ||| IN
neurorehabilitation  ||| S:35 E:55 ||| VBG
This  ||| S:55 E:60 ||| DT
year  ||| S:60 E:65 ||| NN
marks  ||| S:65 E:71 ||| VBZ
the  ||| S:71 E:75 ||| DT
50th  ||| S:75 E:80 ||| JJ
anniversary  ||| S:80 E:92 ||| NN
of  ||| S:92 E:95 ||| IN
the  ||| S:95 E:99 ||| DT
discovery  ||| S:99 E:109 ||| NN
of  ||| S:109 E:112 ||| IN
the  ||| S:112 E:116 ||| DT
laser ||| S:116 E:121 ||| NN
.  ||| S:121 E:123 ||| .
The  ||| S:123 E:127 ||| DT
development  ||| S:127 E:139 ||| NN
of  ||| S:139 E:142 ||| IN
lasers  ||| S:142 E:149 ||| NNS
for  ||| S:149 E:153 ||| IN
medical  ||| S:153 E:161 ||| JJ
use ||| S:161 E:164 ||| NN
,  ||| S:164 E:166 ||| ,
which  ||| S:166 E:172 ||| WDT
became  ||| S:172 E:179 ||| VBD
known  ||| S:179 E:185 ||| VBN
as  ||| S:185 E:188 ||| IN
low-level  ||| S:188 E:198 ||| JJ
laser  ||| S:198 E:204 ||| NN
therapy  ||| S:204 E:212 ||| NN
( ||| S:212 E:213 ||| -LRB-
LLLT ||| S:213 E:217 ||| NNP
)  ||| S:217 E:219 ||| -RRB-
or  ||| S:219 E:222 ||| CC
photobiomodulation ||| S:222 E:240 ||| NN
,  ||| S:240 E:242 ||| ,
followed  ||| S:242 E:251 ||| VBN
in  ||| S:251 E:254 ||| IN
1967 ||| S:254 E:258 ||| CD
.  ||| S:258 E:260 ||| .
In  ||| S:260 E:263 ||| IN
recent  ||| S:263 E:270 ||| JJ
years ||| S:270 E:275 ||| NNS
,  ||| S:275 E:277 ||| ,
LLLT  ||| S:277 E:282 ||| NNP
has  ||| S:282 E:286 ||| VBZ
become  ||| S:286 E:293 ||| VBN
an  ||| S:293 E:296 ||| DT
increasingly  ||| S:296 E:309 ||| RB
mainstream  ||| S:309 E:320 ||| JJ
modality ||| S:320 E:328 ||| NN
,  ||| S:328 E:330 ||| ,
especially  ||| S:330 E:341 ||| RB
in  ||| S:341 E:344 ||| IN
the  ||| S:344 E:348 ||| DT
areas  ||| S:348 E:354 ||| NNS
of  ||| S:354 E:357 ||| IN
physical  ||| S:357 E:366 ||| JJ
medicine  ||| S:366 E:375 ||| NN
and  ||| S:375 E:379 ||| CC
rehabilitation ||| S:379 E:393 ||| NN
.  ||| S:393 E:395 ||| .
At  ||| S:395 E:398 ||| IN
first  ||| S:398 E:404 ||| RB
used  ||| S:404 E:409 ||| VBN
mainly  ||| S:409 E:416 ||| RB
for  ||| S:416 E:420 ||| IN
wound  ||| S:420 E:426 ||| JJ
healing  ||| S:426 E:434 ||| NN
and  ||| S:434 E:438 ||| CC
pain  ||| S:438 E:443 ||| NN
relief ||| S:443 E:449 ||| NN
,  ||| S:449 E:451 ||| ,
the  ||| S:451 E:455 ||| DT
medical  ||| S:455 E:463 ||| JJ
applications  ||| S:463 E:476 ||| NNS
of  ||| S:476 E:479 ||| IN
LLLT  ||| S:479 E:484 ||| NNP
have  ||| S:484 E:489 ||| VBP
broadened  ||| S:489 E:499 ||| VBN
to  ||| S:499 E:502 ||| TO
include  ||| S:502 E:510 ||| VB
diseases  ||| S:510 E:519 ||| NNS
such  ||| S:519 E:524 ||| JJ
as  ||| S:524 E:527 ||| IN
stroke ||| S:527 E:533 ||| NN
,  ||| S:533 E:535 ||| ,
myocardial  ||| S:535 E:546 ||| JJ
infarction ||| S:546 E:556 ||| NN
,  ||| S:556 E:558 ||| ,
and  ||| S:558 E:562 ||| CC
degenerative  ||| S:562 E:575 ||| NNS
or  ||| S:575 E:578 ||| CC
traumatic  ||| S:578 E:588 ||| JJ
brain  ||| S:588 E:594 ||| NN
disorders ||| S:594 E:603 ||| NNS
.  ||| S:603 E:605 ||| .
This  ||| S:605 E:610 ||| DT
review  ||| S:610 E:617 ||| NN
will  ||| S:617 E:622 ||| MD
cover  ||| S:622 E:628 ||| VB
the  ||| S:628 E:632 ||| DT
mechanisms  ||| S:632 E:643 ||| NNS
of  ||| S:643 E:646 ||| IN
LLLT  ||| S:646 E:651 ||| NNP
that  ||| S:651 E:656 ||| WDT
operate  ||| S:656 E:664 ||| VBP
both  ||| S:664 E:669 ||| DT
on  ||| S:669 E:672 ||| IN
a  ||| S:672 E:674 ||| DT
cellular  ||| S:674 E:683 ||| JJ
and  ||| S:683 E:687 ||| CC
a  ||| S:687 E:689 ||| DT
tissue  ||| S:689 E:696 ||| NN
level ||| S:696 E:701 ||| NN
.  ||| S:701 E:703 ||| .
Mitochondria  ||| S:703 E:716 ||| NNS
are  ||| S:716 E:720 ||| VBP
thought  ||| S:720 E:728 ||| VBN
to  ||| S:728 E:731 ||| TO
be  ||| S:731 E:734 ||| VB
the  ||| S:734 E:738 ||| DT
principal  ||| S:738 E:748 ||| JJ
photoreceptors ||| S:748 E:762 ||| NN
,  ||| S:762 E:764 ||| ,
and  ||| S:764 E:768 ||| CC
increased  ||| S:768 E:778 ||| VBD
adenosine  ||| S:778 E:788 ||| JJ
triphosphate ||| S:788 E:800 ||| NN
,  ||| S:800 E:802 ||| ,
reactive  ||| S:802 E:811 ||| JJ
oxygen  ||| S:811 E:818 ||| NN
species ||| S:818 E:825 ||| NNS
,  ||| S:825 E:827 ||| ,
intracellular  ||| S:827 E:841 ||| JJ
calcium ||| S:841 E:848 ||| NN
,  ||| S:848 E:850 ||| ,
and  ||| S:850 E:854 ||| CC
release  ||| S:854 E:862 ||| NN
of  ||| S:862 E:865 ||| IN
nitric  ||| S:865 E:872 ||| JJ
oxide  ||| S:872 E:878 ||| NNS
are  ||| S:878 E:882 ||| VBP
the  ||| S:882 E:886 ||| DT
initial  ||| S:886 E:894 ||| JJ
events ||| S:894 E:900 ||| NNS
.  ||| S:900 E:902 ||| .
Activation  ||| S:902 E:913 ||| NNP
of  ||| S:913 E:916 ||| IN
transcription  ||| S:916 E:930 ||| JJ
factors  ||| S:930 E:938 ||| NNS
then  ||| S:938 E:943 ||| RB
leads  ||| S:943 E:949 ||| VBZ
to  ||| S:949 E:952 ||| TO
expression  ||| S:952 E:963 ||| NN
of  ||| S:963 E:966 ||| IN
many  ||| S:966 E:971 ||| JJ
protective ||| S:971 E:981 ||| NN
,  ||| S:981 E:983 ||| ,
anti-apoptotic ||| S:983 E:997 ||| NNP
,  ||| S:997 E:999 ||| ,
anti-oxidant ||| S:999 E:1011 ||| NNP
,  ||| S:1011 E:1013 ||| ,
and  ||| S:1013 E:1017 ||| CC
pro-proliferation  ||| S:1017 E:1035 ||| JJ
gene  ||| S:1035 E:1040 ||| NN
products ||| S:1040 E:1048 ||| NNS
.  ||| S:1048 E:1050 ||| .
Animal  ||| S:1050 E:1057 ||| JJ
studies  ||| S:1057 E:1065 ||| NNS
and  ||| S:1065 E:1069 ||| CC
human  ||| S:1069 E:1075 ||| JJ
clinical  ||| S:1075 E:1084 ||| JJ
trials  ||| S:1084 E:1091 ||| NNS
of  ||| S:1091 E:1094 ||| IN
LLLT  ||| S:1094 E:1099 ||| NNP
for  ||| S:1099 E:1103 ||| IN
indications  ||| S:1103 E:1115 ||| NNS
with  ||| S:1115 E:1120 ||| IN
relevance  ||| S:1120 E:1130 ||| NN
to  ||| S:1130 E:1133 ||| TO
neurology ||| S:1133 E:1142 ||| VB
,  ||| S:1142 E:1144 ||| ,
such  ||| S:1144 E:1149 ||| JJ
as  ||| S:1149 E:1152 ||| IN
stroke ||| S:1152 E:1158 ||| NN
,  ||| S:1158 E:1160 ||| ,
traumatic  ||| S:1160 E:1170 ||| JJ
brain  ||| S:1170 E:1176 ||| NN
injury ||| S:1176 E:1182 ||| NN
,  ||| S:1182 E:1184 ||| ,
degenerative  ||| S:1184 E:1197 ||| JJ
brain  ||| S:1197 E:1203 ||| NN
disease ||| S:1203 E:1210 ||| NN
,  ||| S:1210 E:1212 ||| ,
spinal  ||| S:1212 E:1219 ||| JJ
cord  ||| S:1219 E:1224 ||| NN
injury ||| S:1224 E:1230 ||| NN
,  ||| S:1230 E:1232 ||| ,
and  ||| S:1232 E:1236 ||| CC
peripheral  ||| S:1236 E:1247 ||| JJ
nerve  ||| S:1247 E:1253 ||| NN
regeneration ||| S:1253 E:1265 ||| NN
,  ||| S:1265 E:1267 ||| ,
will  ||| S:1267 E:1272 ||| MD
be  ||| S:1272 E:1275 ||| VB
covered ||| S:1275 E:1282 ||| VBN
.  ||| S:1282 E:1284 ||| .
